We are medical professionals who are passionate about providing medical services to our ailing patients through clinical research. Our expertise in heart disease is learned through continuous education using evidence-based medicine.
During the height of the COVID-19 pandemic, the need to develop new medications for patients with heart disease is much needed more than ever. Hence, we established Medicus MFC on Jun 15, 2020, to continue our fight against heart disease through clinical research.
Our team of experts in Cardiology launched Medicus MFC's potential in the management of clinical trials. We started with a treatment of a rare disease called Cardiac Amyloidosis. We give our Cardiac Amyloidosis research program participants hope to improve their conditions and knowledge about the disease. Thus, becoming more optimistic about living a better life.
Improvement of our patients’ ailing heart through knowledge and experience gained in clinical research programs.
Educating our participants by Imparting new information on treatments and innovations in the management of heart disease learned through clinical research.
To create a work collaboration with our industry partners and other agencies passionate in developing new treatments for heart disease benefiting our patients.
The brands that trust us with their cardiology research programs.